Abstract

A series of mononuclear Schiff base transition metal complexes of the type [M(LS)(temed)] (where, M = Co(II), Ni(II), Cu(II), and Zn(II); LS = Schiff base ligand derived from L-leucine and Salicylaldehyde and co-ligand temed = N,N,N’N’- tetramethylethylenediamine) have been synthesized and characterized by spectroscopic studies such as Mass, NMR, UV–Visible, FT-IR, and TGA analysis. Spectral results reveal that the metal ions are coordinated to imine nitrogen, phenolic oxygen, and oxygen atom present in the carboxylate group of the Schiff base ligand and two nitrogen atoms from ligand (L2) temed. The scavenging activity of the complexes was carried out by the DPPH method with different concentrations, and all the complexes possesses good antioxidant activity in the range 58.93 to 78.79 %. Among them Zn(II) complex showed higher scavenging activity 78.79 % using 10 mg concentration. Furthermore, an investigation was conducted to assess the antibacterial properties of the complexes. It was observed that all of the metal complexes exhibited significant antimicrobial activity. Notably, the copper complex demonstrated enhanced activity, particularly against S. aureus and Mucor species, with zone of inhibition measurements of 19 mm and 20 mm, respectively. The Zn(II) complex has been used as a precursor to produce zinc oxide nanoparticles by the thermal decomposition method. ZnO nanoparticles have been characterized by powder X-ray diffraction (PXRD), UV–Vis spectroscopy techniques, scanning electron microscopy (SEM), FT-IR spectroscopy. The photocatalytic activity of zinc oxide nanoparticles was investigated in the presence of ultraviolet light. ZnO nanoparticles can efficiently catalyze the degradation of methyl orange, methylene blue, and rhodamine B in the aqueous suspension, and the highest percentage of degradation was observed against methylene blue (99 %). Furthermore, the impact of altering dye concentration, pH, catalyst quantity and kinetics on the photodegradation of model pollutant methylene blue was investigated.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.